This inventor holds 2 USPTO granted patents. Top assignee: Glaxo Group Limited. Active years: 1991-1997.
Location History:
- Biggleswade, GB (1991)
- Greenford, GB (1997)
Company Filing History:
Years Active: 1991-1997
Title: The Innovations of Phillip John Birch
Introduction
Phillip John Birch is a notable inventor based in Greenford, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for neurological conditions. With a total of 2 patents, Birch's work has the potential to impact the lives of many individuals suffering from cerebral ischaemia.
Latest Patents
Birch's latest patents include innovative methods for treating intraocular pressure and protecting mammals against neuronal damage resulting from cerebral ischaemia. His research focuses on the use of a specific compound, identified as (.+-.)-trans-5-fluoro-2,3,3a,9a-tetrahydro-1H-[1,4]-benzodioxino[2,3-c]-pyrrole, particularly in its hydrochloride salt form. These compounds have shown promise in safeguarding mammals, including humans, from neuronal damage associated with cerebral ischaemia.
Career Highlights
Throughout his career, Birch has been associated with Glaxo Group Limited, a leading pharmaceutical company. His work has contributed to advancements in medical treatments, showcasing his dedication to improving health outcomes through innovative research.
Collaborations
Birch has collaborated with various professionals in his field, including his coworker Ann G Hayes. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his research.
Conclusion
Phillip John Birch's contributions to medicinal chemistry and his innovative patents reflect his commitment to advancing medical science. His work continues to pave the way for new treatments that could significantly benefit patients suffering from neurological conditions.